Evidence map›Paper›PMID 38383062›Full record

ArticleGenes & development2024

ATF7IP2/MCAF2 directs H3K9 methylation and meiotic gene regulation in the male germline.

Kris G Alavattam, Jasmine M Esparza, Mengwen Hu, Ryuki Shimada, Anna R Kohrs, Hironori Abe, Yasuhisa Munakata, Kai Otsuka, Saori Yoshimura, Yuka Kitamura and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Many Faces of SetDB1.Epigenomes · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epigenetic priming in the male germline.Current opinion in genetics & development · 2024
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Kris G Alavattam *Reproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0003-1696-6515
Jasmine M Esparza *Department of Microbiology and Molecular Genetics, University of California, Davis, Davis, California 95616, USA.ORCID 0000-0001-8222-0450
Mengwen Hu *Reproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0002-7480-6432
Ryuki Shimada *Department of Chromosome Biology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0001-6724-0875
Anna R KohrsReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
Hironori AbeReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0003-2266-162X
Yasuhisa MunakataReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0002-5134-0828
Kai OtsukaDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California 95616, USA.ORCID 0000-0002-7573-010X
Saori YoshimuraDepartment of Chromosome Biology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Kumamoto 860-0811, Japan.
Yuka KitamuraDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California 95616, USA.ORCID 0009-0001-7403-0902
Yu-Han YehReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0003-2369-4415
Yueh-Chiang HuReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.ORCID 0000-0002-7992-0525
Jihye KimLaboratory of Chromosome Dynamics, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032, Japan.
Paul R AndreassenDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 49229, USA.ORCID 0000-0002-9760-1595
Kei-Ichiro IshiguroDepartment of Chromosome Biology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Kumamoto 860-0811, Japan; snamekawa@ucdavis.edu ishiguro@kumamoto-u.ac.jp.ORCID 0000-0002-7515-1511
Satoshi H NamekawaReproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA; snamekawa@ucdavis.edu ishiguro@kumamoto-u.ac.jp.ORCID 0000-0002-1052-943X
Cincinnati Children's Hospital Medical Center · USKumamoto University · JPUniversity of California, Davis · USChemical Dynamics (United States) · US

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
Epigenetic gene regulations in the germlineR35GM141085 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Satoshi Namekawa · 2021 to 2026
$4.4M
DNA Damage Response Pathways in Meiotic Sex Chromosome InactivationR01GM098605 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAMEKAWA, SATOSHI · 2011 to 2020
$3.3M
Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage responseR01GM134731 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ANDREASSEN, PAUL R · 2019 to 2022
$1.3M
NIGMS NIH HHS R01 GM098605NIGMS NIH HHS R01 GM134731NIGMS NIH HHS R35 GM141085NIGMS NIH HHS T32 GM007377
6 · The paper itself

Abstract

H3K9 trimethylation (H3K9me3) plays emerging roles in gene regulation, beyond its accumulation on pericentric constitutive heterochromatin. It remains a mystery why and how H3K9me3 undergoes dynamic regulation in male meiosis. Here, we identify a novel, critical regulator of H3K9 methylation and spermatogenic heterochromatin organization: the germline-specific protein ATF7IP2 (MCAF2). We show that in male meiosis, ATF7IP2 amasses on autosomal and X-pericentric heterochromatin, spreads through the entirety of the sex chromosomes, and accumulates on thousands of autosomal promoters and retrotransposon loci. On the sex chromosomes, which undergo meiotic sex chromosome inactivation (MSCI), the DNA damage response pathway recruits ATF7IP2 to X-pericentric heterochromatin, where it facilitates the recruitment of SETDB1, a histone methyltransferase that catalyzes H3K9me3. In the absence of ATF7IP2, male germ cells are arrested in meiotic prophase I. Analyses of ATF7IP2-deficient meiosis reveal the protein's essential roles in the maintenance of MSCI, suppression of retrotransposons, and global up-regulation of autosomal genes. We propose that ATF7IP2 is a downstream effector of the DDR pathway in meiosis that coordinates the organization of heterochromatin and gene regulation through the spatial regulation of SETDB1-mediated H3K9me3 deposition.

Indexed as

HeterochromatinHistonesAnimalsGerm CellsMaleMeiosisMethylationMiceHeterochromatinHistonesATF7IP2/MCAF2constitutive heterochromatingene activationH3K9me3meiosismeiotic sex chromosome inactivation

Identifiers

PMID38383062
PMCPMC10982687
OpenAlexW4391994220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.